Transcatheter arterial chemoembolization combined with CT-guided percutaneous thermal ablation versus hepatectomy in the treatment of hepatocellular carcinoma

Table 1 Comparison of the clinical parameters between the two groups of patients with hepatocellular carcinoma (HCC)

Matched variable	Combination group (n = 137)	Surgery group (n = 148)	P
Age (years)			0.093
Median	51	54
Range	23–74	23–75
Sex^a			0.183
Male	129	133
Female	8	15
Hypersplenism^a			0.281
Yes	74	70
No	63	78
Child-Pugh class^a			0.193
A	124	140
B	13	8
Cirrhosis^a			0.432
Yes	118	132
No	19	16
Diabetes mellitus^a			0.296
No	118	134
Yes	19	14
Tumor number^a			0.582
1	59	69
2	43	50
3	28	21
4	7	8
Tumor size^a			0.992
≤3 cm	61	68
>3 cm and ≤5 cm	47	49
>5 cm and ≤7 cm	23	24
>7 cm and ≤10 cm	6	7
Alpha fetoprotein^a			0.292
≥400 ng/mL	34	45
<400 ng/mL	103	103
Size of all nodules in diameter (cm)			0.364
Median	3.8	4.0
Mean ± standard deviation	37.0 ± 17.5	38.9 ± 18.1
Albumin (g/L)	40.8 ± 4.3	41.6 ± 4.2	0.133
Prothrombin time (s)	12.6 ± 2.0	13.0 ± 2.1	0.075
Platelet count (×10⁹/L)	128.2 ± 64.8	145.1 ± 60.0	*0.022*
Hemoglobin (g/L)	135.9 ± 16.2	138.7 ± 16.8	0.156
CA19-9 (U/mL)	140.4 ± 852.2	79.8 ± 531.0	0.469

^aThe values are presented as number of patients. Tumor size, the largest lesion in diameter.

ISSN: 2523-3548